Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Days after the brutal execution of 37-year-old Alex Pretti in Minneapolis, we still don’t know the identities of the masked ICE agents who shot him dead. They fled the scene and are nowhere to be ...